- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01948505
Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit
To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient pain.
To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels in neurocritically ill patients.
To assess the effect of an intravenous nonnarcotic pain medication on common side effects seen in patients taking other intravenous narcotic pain medication in the neurocritical care unit.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- > 45 kg (amenable to adult dosing)
- all traumatic brain injuries NPO for at least 12 hours
- all post-operative craniotomy patients
- all non-operative subarachnoid hemorrhage, intraparenchymal hemorrhage, and stroke patients
- all carotid endarterectomy and carotid artery stenosis patients
- all endovascular patients undergoing intracranial intervention
- all post-op spine patients admitted to the NCCU
Exclusion Criteria:
- documented allergy to acetaminophen
- documented severe hepatic impairment (Child-Pugh score > 6) or severe hepatic disease (hepatitis)
- documented severe renal impairment (CrCl < 30 ml/min) Blood tests will be performed prior to study procedures that will ensure patients do not have renal impairment.
- patients who are pregnant or breast feeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intervention group
IV acetaminophen: 1000mg IV q 8 hrs (scheduled) until: a) tolerating PO and IV saline-locked or b) 48 hours reached on medication
|
|
Placebo Comparator: Placebo Group
IV Normal Saline: 100ml IV q 8 hrs (scheduled) until: a) tolerating PO and IV saline-locked or b) 48 hours reached on medication
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Narcotic Requirement After Surgery
Time Frame: 48 hours
|
The primary efficacy end point was narcotic consumption during the first 48 hours after craniotomy.
Opioid usage was calculated by converting the amount of the narcotics taken by the patient into oral morphine equivalents (ME), which were totaled for each postoperative day.
At 48 hours after surgery, patients who received IV acetaminophen in addition to our standardized pain protocol did not have a statistically significantly lower mean narcotic requirement, measured in ME, when compared with those in the placebo group.
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sedation level as measured on the Riker Scale (1-7)
Time Frame: 48 hours
|
48 hours
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Frequency of Nausea, Vomiting, Urinary Retention & Constipation
Time Frame: 48 hours
|
48 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arterial Occlusive Diseases
- Wounds and Injuries
- Craniocerebral Trauma
- Trauma, Nervous System
- Carotid Artery Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Carotid Stenosis
- Physiological Effects of Drugs
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Antipyretics
- Acetaminophen
Other Study ID Numbers
- 00061838
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-operative Craniotomy Patients
-
University of California, DavisCompleted
-
Siriraj HospitalUnknownPatient Relations, Nurse | Post-operative PatientsThailand
-
University Hospital, CaenCompleted
-
EarlySense Ltd.WithdrawnPost Operative Patient | Patients Requiring PCA | Respiratory Patients | Patients in Risk of FallUnited States
-
Beth Israel Deaconess Medical CenterWithdrawnPost-operative Recovery for Cesarean Hysterectomy PatientsUnited States
-
Bispebjerg HospitalCompletedRehabilitation Strategies for Elderly Post-Operative PatientsDenmark
-
Minia UniversityMinia University HospitalRecruitingPatients Undergoing Elective CraniotomyEgypt
-
Isfahan University of Medical SciencesUnknownElective Craniotomy-candidated PatientsIran, Islamic Republic of
-
Tokyo Women's Medical UniversityBaxter Healthcare CorporationUnknownPatients Undergoing Elective CraniotomyJapan
-
Charite University, Berlin, GermanyCompletedFrailty | Surgery | Older PatientsGermany
Clinical Trials on Intravenous acetaminophen
-
University Health Network, TorontoNot yet recruitingSurgery | Hip-fracture
-
Hamad Medical CorporationRecruiting
-
Medical University of South CarolinaCompletedPain, PostoperativeUnited States
-
Duke UniversityCompletedOsteoarthritis | Acetaminophen | Arthroplasty, Hip ReplacementUnited States
-
Richmond University Medical CenterUnknownFever | Oxidative StressUnited States
-
University of California, San DiegoCadence PharmaceuticalsWithdrawnPostoperative Pain | Intraoperative and Postoperative Opioid RequirementsUnited States
-
Aultman Health FoundationCompletedPostoperative Pain | Opioid Use | AcetaminophenUnited States
-
Thomas Jefferson UniversityUnknown
-
University of Texas Southwestern Medical CenterCompleted
-
Children's Hospital Medical Center, CincinnatiWithdrawnTonsillectomy | Adenoidectomy